CSF1 and arthritic joint disease: Blockade of CSF1 alone or of both CSF1/IL34 for 9 weeks reduced arthritis compared to treatment with the aRW control (Figure 2G) and histologically (Figure 2H), including a reduction of bone remodeling (Figure 2I).